An overview of prognostic factors for long-term survivors of breast cancer
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Numerous studies have examined prognostic factors for survival of breast cancer patients, but relatively few have dealt specifically with 10+-year survivors. METHODS: A review of the PubMed database from 1995 to 2006 was undertaken with the following inclusion criteria: median/mean follow-up time at least 10 years; overall survival and/or disease-specific survival known; and relative risk and statistical probability values reported. In addition, we used data from the long-standing Eindhoven Cancer Registry to illustrate survival probability as indicated by various prognostic factors. RESULTS: 10-year breast cancer survivors showed 90% 5-year relative survival. Tumor size, nodal status and grade remained the most important prognostic factors for long-term survival, although their role decreased over time. Most studies agreed on the long-term prognostic values of MI (mitotic index), LVI (lymphovascular invasion), Her2-positivity, gene profiling and comorbidity for either all or a subgroup of breast cancer patients (node-positive or negative). The roles of age, socioeconomic status, histological type, BRCA and p53 mutation were mixed, often decreasing after correction for stronger prognosticators, thus limiting their clinical value. Local and regional recurrence, metastases and second cancer may substantially impair long-term survival. Healthy lifestyle was consistently related to lower overall mortality. CONCLUSIONS: Effects of traditional prognostic factors persist in the long term and more recent factors need further follow-up. The prognosis for breast cancer patients who have survived at least 10 years is favourable and increases over time. Improved long-term survival can be achieved by earlier detection, more effective modern therapy and healthier lifestyle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536 · cited 1×
“clustered and segregated into major subgroups; BC with a good and poor prognosis profile is correlated to the probability of distant metastases [72] or a tumour with basal or luminal characteristics which are strongly associated with ER status [73].”
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Sotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
Haagenson, C. (1971) · Cited by 1,773
Physical activity and survival after breast cancer diagnosis
Holmes, M. D. (2005) · JAMA · doi:10.1001/jama.293.20.2479 · Cited by 1,772
Long-term effects of mammography screening: updated overview of the Swedish randomised trials
Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., & Rutqvist, L. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08020-0 · Cited by 1,183
Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi326 · Cited by 1,127
The Nottingham prognostic index in primary breast cancer
Galea, M. H., Blamey, R. W., Elston, C. E., & Ellis, I. O. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01840834 · Cited by 1,070
Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0966-pfibc · Cited by 1,016
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
Sant, M., Aareleid, T., Berrino, F., Bielska Lasota, M., Carli, P. M., Faivre, J., Grosclaude, P., Hédelin, G., Matsuda, T., Møller, H., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg754 · Cited by 1,011
Doyle, C., Kushi, L. H., Byers, T., Courneya, K. S., Demark-Wahnefried, W., Grant, B., McTiernan, A., Rock, C. L., Thompson, C., Gansler, T., et al. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.6.323 · Cited by 950 · cited 1×
“So far, although studies have not convincingly shown the positive influence of eating fruit, vegetables and soy bean on long-term BC survival [85, 88], diets high in fruits, vegetables, legumes, poultry, and fish and a low intake of red meat, desserts and high fat dairy products are likely to protect against mortality…”
Tabar, L., Yen, M.-F., Vitak, B., Chen, H.-H. T., Smith, R. A., & Duffy, S. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13143-1 · Cited by 742
UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years
Peto, R., Boreham, J., Clarke, M., Davies, C., & Beral, V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02277-7 · Cited by 648
HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
Pritchard, K. I., Shepherd, L. E., O'Malley, F. P., Andrulis, I. L., Tu, D., Bramwell, V. H., & Levine, M. N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054504 · Cited by 509
Habel, L. A., Shak, S., Jacobs, M. K., Capra, A., Alexander, C., Pho, M., Baker, J., Walker, M., Watson, D., Hackett, J., et al. (2006) · Breast Cancer Research · doi:10.1186/bcr1412 · Cited by 484
Wapnir, I. L., Anderson, S. J., Mamounas, E. P., Geyer, C. E., Jeong, J.-H., Tan-Chiu, E., Fisher, B., & Wolmark, N. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3273 · Cited by 466
Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer
Tammemagi, C. M. (2005) · JAMA · doi:10.1001/jama.294.14.1765 · Cited by 432
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening
Alexander, F., Anderson, T., Brown, H., Forrest, A., Hepburn, W., Kirkpatrick, A., Muir, B., Prescott, R., & Smith, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07413-3 · Cited by 388
Newman, L. A., Griffith, K. A., Jatoi, I., Simon, M. S., Crowe, J. P., & Colditz, G. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3472 · Cited by 362
Fisher, B., Jeong, J.-H., Bryant, J., Anderson, S., Dignam, J., Fisher, E. R., & Wolmark, N. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16981-x · Cited by 359
Otto, S. J., Fracheboud, J., Looman, C. W., Broeders, M. J., Boer, R., Hendriks, J. H., Verbeek, A. L., & de Koning, H. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13132-7 · Cited by 333
The natural history of breast carcinoma: what have we learned from screening?
Tabár, L., Duffy, S. W., Viták, B., Chen, H. H., & Prevost, T. C. (1999) · PubMed · Cited by 329
Harris, J. R. (2014) · Cited by 325
Period analysis for ‘up-to-date’ cancer survival data
Brenner, H., Gefeller, O., & Hakulinen, T. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.10.013 · Cited by 309
Robson, M. E., Chappuis, P. O., Satagopan, J., Wong, N., Boyd, J., Goffin, J. R., Hudis, C., Roberge, D., Norton, L., Bégin, L. R., et al. (2003) · Breast Cancer Research · doi:10.1186/bcr658 · Cited by 307
Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study
Mansi, J. L., Gogas, H., Biss, J. M., Gazet, J.-C., Berger, U., & Coombes, R. C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10175-7 · Cited by 295
Brown, J. K., Byers, T., Doyle, C., Courneya, K. S., Demark-Wahnefried, W., Kushi, L. H., McTiernan, A., Rock, C. L., Aziz, N., Bloch, A. S., et al. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.5.268 · Cited by 292
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Aebi, S., Gelber, S., Castiglione-Gertsch, M., Gelber, R., Collins, J., Thürlimann, B., Rudenstam, C., Lindtner, J., Crivellari, D., Cortes-Funes, H., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02292-3 · Cited by 287
Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer
Schoppmann, S. F., Bayer, G., Aumayr, K., Taucher, S., Geleff, S., Rudas, M., Kubista, E., Hausmaninger, H., Samonigg, H., Gnant, M., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133355.48672.22 · Cited by 281
Berclaz, G., Li, S., Price, K. N., Coates, A. S., Castiglione-Gertsch, M., Rudenstam, C.-M., Holmberg, S. B., Lindtner, J., Erien, D., Collins, J., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh222 · Cited by 257
Breast cancer incidence and mortality trends in 16 European countries
Botha, J. L., Bray, F., Sankila, R., & Parkin, D. M. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00118-7 · Cited by 254
Shen, Y., Yang, Y., Inoue, L. Y. T., Munsell, M. F., Miller, A. B., & Berry, D. A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji239 · Cited by 249
Mirza, A. N., Mirza, N. Q., Vlastos, G., & Singletary, S. E. (2002) · Annals of Surgery · doi:10.1097/00000658-200201000-00003 · Cited by 246
Hurley, J., Doliny, P., Reis, I., Silva, O., Gomez-Fernandez, C., Velez, P., Pauletti, G., Powell, J. E., Pegram, M. D., & Slamon, D. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8886 · Cited by 245 · cited 1×
“Emerging new therapeutic approaches using a monoclonal antibody directed against HER-2 have yielded improved short-term survival for advanced stage [106] as well as operable BC patients [107].”
Louwman, W. J., Janssen-Heijnen, M. L. G., Houterman, S., Voogd, A. C., van der Sangen, M. J. C., Nieuwenhuijzen, G. A. P., & Coebergh, J. W. W. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.025 · Cited by 227
Self-citationDignam, J. J. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg060 · Cited by 223
Dietary factors and the survival of women with breast carcinoma
Holmes, M. D., Stampfer, M. J., Colditz, G. A., Rosner, B., Hunter, D. J., & Willett, W. C. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990901)86:5<826::aid-cncr19>3.0.co;2-0 · Cited by 220
Fisher, E. R., Anderson, S., Tan-Chiu, E., Fisher, B., Eaton, L., & Wolmark, N. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8+<1679::aid-cncr1183>3.0.co;2-8 · Cited by 217
Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study
Hooning, M. J., Aleman, B. M. P., van Rosmalen, A. J. M., Kuenen, M. A., Klijn, J. G. M., & van Leeuwen, F. E. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.10.022 · Cited by 207
Dietary Patterns and Survival After Breast Cancer Diagnosis
Kroenke, C. H., Fung, T. T., Hu, F. B., & Holmes, M. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0198 · Cited by 207
D'Eredita', G., Giardina, C., Martellotta, M., Natale, T., & Ferrarese, F. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00435-4 · Cited by 177
Thomson, C. S., Hole, D. J., Twelves, C. J., Brewster, D. H., & Black, R. J. (2001) · Journal of Epidemiology and Community Health · doi:10.1136/jech.55.5.308 · Cited by 163
Wójcik, B. E., Spinks, M. K., & Optenberg, S. A. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980401)82:7<1310::aid-cncr14>3.0.co;2-9 · Cited by 160
Obedian, E., FISCHER, D. B., & Haffty, B. G. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2406 · Cited by 148
Established breast cancer risk factors by clinically important tumour characteristics
García‐Closas, M., Brinton, L. A., Lissowska, J., Chatterjee, N., Pepłońska, B., Anderson, W. F., Szeszenia‐Dąbrowska, N., Bardin‐Mikolajczak, A., Zatoński, W. A., Blair, A. E., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603207 · Cited by 145
Chia, S., Speers, C. H., Bryce, C. J., Hayes, M. M., & Olivotto, I. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.070 · Cited by 144
Lee, A. H. S., Pinder, S. E., Macmillan, R. D., Mitchell, M., Ellis, I. O., Elston, C. W., & Blamey, R. W. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.10.021 · Cited by 137
Suzuki, R., Ye, W., Rylander-Rudqvist, T., Saji, S., Colditz, G. A., & Wolk, A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji341 · Cited by 136
Comorbidity and breast cancer survival: A comparison between black and white women
West, D. W., Satariano, W. A., Ragland, D. R., & Hiatt, R. A. (1996) · Annals of Epidemiology · doi:10.1016/s1047-2797(96)00096-8 · Cited by 131
Interobserver reproducibility of histopathological features in stage II breast cancer
Gilchrist, K. W., Kalish, L. A., Gould, V. E., Hirschl, S., Imbriglia, J. E., Levy, W. M., Patchefsky, A. S., Penner, D. W., Pickren, J. W., Roth, J. A., et al. (1985) · Breast Cancer Research and Treatment · doi:10.1007/bf01807642 · Cited by 125
Liu, S., Edgerton, S. M., Moore, D. H., & Thor, A. D. (2001) · PubMed · Cited by 122
Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations
Gaffney, D. K., Brohet, R. M., Lewis, C. M., Holden, J. A., Buys, S. S., Neuhausen, S. L., Steele, L., Avizonis, V. N., Stewart, J. R., & Cannon‐Albright, L. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00023-1 · Cited by 119
Social class is an important and independent prognostic factor of breast cancer mortality
Bouchardy, C., Verkooijen, H. M., & Fioretta, G. (2006) · International Journal of Cancer · doi:10.1002/ijc.21889 · Cited by 112
Suzuki, R., Rylander‐Rudqvist, T., Ye, W., Saji, S., & Wolk, A. (2006) · International Journal of Cancer · doi:10.1002/ijc.22034 · Cited by 112
Dignam, J. J., Wieand, K., Johnson, K. A., Raich, P. C., Anderson, S., Somkin, C. P., & Wickerham, D. L. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9118-3 · Cited by 108
Multiple primary tumours in women following breast cancer, 1973–2000
Raymond, J. S., & HOGUE, C. J. R. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603172 · Cited by 105
Vu-Nishino, H., Tavassoli, F. A., Ahrens, W. A., & Haffty, B. G. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.008 · Cited by 103
Voogd, A. C., van Oost, F. J., Rutgers, E. J. T., Elkhuizen, P. H. M., van Geel, A. N., Scheijmans, L. J. E. E., van der Sangen, M. J. C., Botke, G., Hoekstra, C. J. M., Jobsen, J. J., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.040 · Cited by 95
Self-citationFrković‐Grazio, S., & Bračko, M. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.2.88 · Cited by 95
Are Patients Diagnosed With Breast Cancer Before Age 50 Years Ever Cured?
Brenner, H., & Hakulinen, T. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.067 · Cited by 90
Fisher, B., Jeong, J., Anderson, S., & Wolmark, N. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh338 · Cited by 88
Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis.
Ferrero-Poüs, M., Hacène, K., Bouchet, C., Doussal, V. L., Tubiana-Hulin, M., & Spyratos, F. (2000) · PubMed · Cited by 85
Time‐dependent effects on survival in breast carcinoma
Warwick, J., Tabàr, L., Viták, B., & Duffy, S. W. (2004) · Cancer · doi:10.1002/cncr.20140 · Cited by 85
Galper, S., Blood, E., Gelman, R. S., Abner, A. L., Recht, A., Kohli, A., Wong, J. S., Smith, D. N., Bellon, J. R., Connolly, J. L., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.06.011 · Cited by 79
Estrogen, Estrogen Plus Progestin Therapy, and Risk of Breast Cancer
Colditz, G. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.909s.11.2 · Cited by 79
Haerslev, T., Jacobsen, G. K., & Zedeler, K. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806492 · Cited by 70
for the EDISC group, Menvielle, G., Leclerc, A., Chastang, J., & Luce, D. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602907 · Cited by 68
Eerola, H., Vahteristo, P., Sarantaus, L., Kyyr�nen, P., Pyrh�nen, S., Blomqvist, C., Pukkala, E., Nevanlinna, H., & Sankila, R. (2001) · International Journal of Cancer · doi:10.1002/ijc.1341 · Cited by 65
Weiss, R. B., Woolf, S., Demakos, E. P., Holland, J. F., Berry, D. A., Falkson, G., Cirrincione, C., Robbins, A., Bothun, S. M., Henderson, I. C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.006 · Cited by 64
Costa, S. D., Lange, S., Klinga, K., Merkle, E., & Kaufmann, M. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00067-9 · Cited by 60
Dalès, J.-P., Garcia, S., Carpentier, S., Andrac, L., Ramuz, O., Lavaut, M. N., Allasia, C., Bonnier, P., & Charpin, C. (2004) · Human Pathology · doi:10.1016/j.humpath.2003.10.008 · Cited by 59
Expression of p53 protein has no independent prognostic value in breast cancer
Pietiläinen, T., Lipponen, P., Aaltomaa, S. H., Eskelinen, M. J., Kosma, V., & Syrjänen, K. J. (1995) · The Journal of Pathology · doi:10.1002/path.1711770303 · Cited by 41
Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis
Houterman, S., Janssen-Heijnen, M. L. G., van de Poll-Franse, L. V., Brenner, H., & Coebergh, J. W. W. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj139 · Cited by 37
Self-citationRobsahm, T. E., & Tretli, S. (2005) · European Journal of Cancer Prevention · doi:10.1097/00008469-200502000-00002 · Cited by 35
Prognostic impact of second cancer on the survival of early breast cancer patients.
Nomura, Y., Tsutsui, S., Murakami, S., et al. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.6.1103 · Cited by 10
A Weight Loss Trial for Breast Cancer Recurrence: Pre-Menopausal, Post-Menopausal, Both, or Neither?
Byers, T., & Sedjo, R. L. (2006) · Cancer Causes & Control · doi:10.1007/s10552-005-0547-4 · Cited by 8
Takeuchi, H., Baba, H., Kano, T., & Maehara, Y. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9014-x · Cited by 7
Cited by
Youlden, D. R., Cramb, S. M., Dunn, N. A. M., Muller, J. M., Pyke, C. M., & Baade, P. D. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.02.007 · Cited by 709
Elsheikh, S. E., Green, A. R., Rakha, E. A., Powe, D. G., Ahmed, R. A., Collins, H. M., Soria, D., Garibaldi, J. M., Paish, C. E., Ammar, A. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3907 · Cited by 511
Clinical Outcomes and Correlates of TP53 Mutations and Cancer
Robles, A. I., & Harris, C. C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001016 · Cited by 394
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
Lowery, A. J., Kell, M. R., Glynn, R. W., Kerin, M. J., & Sweeney, K. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1891-6 · Cited by 389
Torres Lacomba, M., Yuste Sanchez, M. J., Zapico Goni, A., Prieto Merino, D., Mayoral del Moral, O., Cerezo Tellez, E., & Minayo Mogollon, E. (2010) · BMJ · doi:10.1136/bmj.b5396 · Cited by 385
Metadata
- Authors
- Soerjomataram, I., Louwman, M. W. J., Ribot, J. G., Roukema, J. A., & Coebergh, J. W. W.
- Venue
- Breast Cancer Research and Treatment
- Published
- 2007-03-22
- Volume
- 107
- Issue
- 3
- Pages
- 309-330
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W1965427258
- Cited by
- 513
- References
- 85
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.